GLP-1 medication scams are rising fast. Learn how fake pharmacies, ads, and messages work — and how to spot them early.

A US investment bank is already eyeing the benefits of lighter passengers for the airlines in reduced fuel costs.

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

The Apprentice star has been the subject of chatter after losing a significant amount of weight ...

In 2018, Health Canada authorized semaglutide injections — more famously known by the brand name Ozempic — for blood sugar ...

Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...

Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly ...

The approaching expiration of Ozempic’s Brazilian patent—a diabetes drug widely used for weight loss—has triggered a dispute in Congress. Denmark’s Novo Nordisk, whose patent expires in March, is ...

A ’nuanced’ look at the implications of weight-loss drugs ...

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...